Related Experiment Video
Updated: Oct 24, 2025

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
Published on: January 5, 2018
Alterations of Signaling Pathways in Essential Thrombocythemia with Calreticulin Mutation
Wuhan Hui1, Wei Zhang1, Congyan Liu1
1Department of Hematology, Xuan Wu Hospital, Capital Medical University, Beijing, People's Republic of China.
Purpose:
Though mutations of the calreticulin (CALR) gene have been identified in essential thrombocythemia patients, the detailed mechanisms for CALR mutations have not been completely clarified. Our study is aimed at characterizing alteration of protein expression in ET patients with mutated CALR and further recognizing possible involvement of signaling pathways associated with CALR mutations.
Patients And Methods:
Protein pathway array was performed to analyze the expression levels of proteins involved in various signaling pathways in peripheral blood neutrophils from 18 ET patients with mutated CALR , 20 ET patients with JAK2 mutation and 20 controls.
Results:
We found 20 proteins differentially expressed in ET patients with mutated CALR compared with healthy controls. These proteins were associated with molecular mechanisms of cancer in ingenuity pathways analysis (IPA) network. We identified top ten canonical pathways which including apoptotic pathways and cellular cytokine pathways might participate in pathogenesis of ET with mutated CALR . Additionally, there were 8 proteins found to be dysregulated differently between ET patients with mutated CALR and those with JAK2 mutation. These proteins might be related to the unique signaling pathways activated by CALR mutation which were different to JAK/STATs pathway by JAK2 mutation.
Conclusion:
Our study demonstrated that numerous alterations of signaling proteins and pathways in ET patients with mutated CALR . These findings could help to gain insights into the pathological mechanisms of ET.
Insights
Mutations in the calreticulin (CALR) gene are linked to essential thrombocythemia (ET). This study reveals significant protein and pathway alterations in ET patients with CALR mutations, offering insights into disease mechanisms.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Calreticulin (CALR) gene mutations are observed in essential thrombocythemia (ET).
- The precise molecular mechanisms underlying CALR mutations in ET remain incompletely understood.
- Characterizing protein expression alterations is crucial for elucidating ET pathogenesis.
Purpose of the Study:
- To investigate protein expression changes in ET patients with CALR mutations.
- To identify signaling pathways potentially involved in CALR-mutated ET.
- To compare molecular profiles between CALR-mutated ET and JAK2-mutated ET.
Main Methods:
- Protein pathway array analysis was conducted on neutrophils.
- Study included 18 ET patients with CALR mutations, 20 ET patients with JAK2 mutations, and 20 healthy controls.
- Ingenuity Pathway Analysis (IPA) was used for network and pathway analysis.
Main Results:
- Twenty proteins were differentially expressed in CALR-mutated ET compared to controls, linked to cancer pathways.
- Apoptotic and cellular cytokine pathways were identified as potentially participating in CALR-mutated ET pathogenesis.
- Eight proteins showed differential dysregulation between CALR-mutated ET and JAK2-mutated ET, suggesting distinct signaling.
Conclusions:
- Significant alterations in signaling proteins and pathways are evident in ET patients with CALR mutations.
- These findings contribute to a deeper understanding of the pathological mechanisms in ET.
- The study highlights potential differences in signaling pathways activated by CALR versus JAK2 mutations.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

